(1S,2S)-2-aminocyclobutan-1-ol

Inquiry

Cat Number

INT1820572131

CAS Number

1820572-13-1

If you have any other questions, please contact our experts.

Product Detail Description Customer Q&A

CAS Number

1820572-13-1

Synonyms

Cyclobutanol, 2-amino-, (1S,2S)-;(1S, 2S)-2-Amino-cyclobutanol

Molecular Formula

C4H9NO

Molecular Weight

87.12

Smiles

C1CC(C1N)O

General Description

(1S,2S)-2-aminocyclobutan-1-ol is a chiral cyclic amino acid, the (1S,2S) enantiomer of 2-aminocyclopropanecarboxylic acid.

Mechanism of Action

It functions as a conformational constraint. As a single enantiomer, it ensures that the incorporated cyclic motif has a specific three-dimensional orientation for precise target interaction.

Application

It is primarily used in the development of chiral pharmaceuticals and as a component in specialized therapeutic peptide research.

Is (1S,2S)-2-aminocyclobutan-1-ol chiral?

Yes, it is produced as a high-purity (1S,2S) enantiomer.

How to store (1S,2S)-2-aminocyclobutan-1-ol?

It should be stored in a cool, dry area in a sealed container.

Does it meet industry standards?

Yes, its production is compliant with international industry standards.

Is global shipping available?

Yes, we provide international logistics for it according to regulations.

What is the primary use of (1S,2S)-2-aminocyclobutan-1-ol?

It acts as a chiral building block for pharmaceutical discovery.

You Might Also Like

4'-Bromomethyl-2-cyanobiphenyl

Cat NO.: INT114772542
CAS NO.: 114772-54-2

View Details

Pyrimidin-2,4,6-triamin

Cat NO.: INT1004382
CAS NO.: 1004-38-2

View Details

2,3-Dihydro-1-oxo-1H-indene-4-carbonitrile

Cat NO.: INT60899345
CAS NO.: 60899-34-5

View Details

4,4-Dimethyl-2,6-dioxopiperidine-3,5-dicarbonitrile

Cat NO.: INT61193042
CAS NO.: 61193-04-2

View Details

HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

INFORMATION

Member of

CERTIFICATION

USA

Tel:
Email:
Address:

Denmark

Tel:
Email:
Address:

WhatsAPP (Sales #1)

WhatsAPP (Sales #2)

WhatsAPP (Sales #3)